Immunotherapy Advances

Oxford University Press

Journal websitePeer review: Peer review
Evaluation status available after sign-in

About the journal

Immunotherapy Advances is an open-access journal published by Oxford University Press in United Kingdom, publishing in english. It is listed in DOAJ according to the sources read. Declared publication charge: 2,205 GBP. Declared review time at DOAJ: 7 weeks. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.

Basic facts

Publisher
Oxford University Press
ISSN
2732-4303
Country
United Kingdom
Languages
english
Access
Open access
Declared publication charge
2,205 GBP
Articles in DOAJ
0
Declared review time
7 weeks
Declared peer-review model
peer_review

Index listings

  • DOAJ · 2021-05-06
Indexing
DOAJ
APC
2,205 GBP
Declared review time (DOAJ)
7 weeks — journal-declared only (not measured)
Activity (OpenAlex)
Active — latest works 2026
PublishLens list status
Shown after sign-in
Counts for promotion at your university?
Choose your university and rank below ↓

Methodology signals (dated facts from their sources)

Details of the evaluation under the published methodology are shown to signed-in users (free).

Create a free account to view the evaluation

Journal profile

Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.

Articles in DOAJ

0

Average review time (journal-declared via DOAJ)

7weeks

Works in OpenAlex

151

Last recorded publication year

2026

Reported by OpenAlex in 2 of 3 sources (CC0 flags, not verified indexing)DOAJSciELOOpenAlex Core

h-index

23

i10-index

55

From OpenAlex open data (CC0).

Editorial & policy12
Last DOAJ review date
2024-04-03
Added to DOAJ
2021-05-06
Declared plagiarism screening
Not declared
Other fees beyond APC
No
Declared digital preservation
Portico
Observed digital preservation (Keepers registry)— snapshot 2026-10-05
CLOCKSSPortico
Editorial board
Official page ↗
Open references deposited at Crossref
93%
ORCID iDs in current deposits
94%
Enrolled in Crossref Similarity Check
✓
Deposits licence metadata at Crossref
✓
APC waiver policy
View policy
Peer-review policy
View policy
Identity & continuity2
Source type
journal
NLM unique ID (PubMed)
101776979
Classification4

Subjects (DOAJ)

Medicine: Internal medicine: Specialties of internal medicine: Immunologic diseases. AllergyMedicine: Therapeutics. Pharmacology

LCC codes

RC581-607RM1-950

Subject areas

  • Immunotherapy and Immune Responses
  • Immunotherapy and Immune Responses
  • CAR-T cell therapy research
  • CAR-T cell therapy research
  • Immune Cell Function and Interaction
  • Immune Cell Function and Interaction
  • Cancer Immunotherapy and Biomarkers
  • Cancer Immunotherapy and Biomarkers
Show all subjects (50)
  • T-cell and B-cell Immunology
  • T-cell and B-cell Immunology
  • Monoclonal and Polyclonal Antibodies Research
  • Monoclonal and Polyclonal Antibodies Research
  • Immune cells in cancer
  • Immune cells in cancer
  • Virus-based gene therapy research
  • Allergic Rhinitis and Sensitization
  • Allergic Rhinitis and Sensitization
  • Diabetes and associated disorders
  • Virus-based gene therapy research
  • Diabetes and associated disorders
  • vaccines and immunoinformatics approaches
  • vaccines and immunoinformatics approaches
  • Hematopoietic Stem Cell Transplantation
  • Hematopoietic Stem Cell Transplantation
  • SARS-CoV-2 and COVID-19 Research
  • Diabetes Management and Research
  • SARS-CoV-2 and COVID-19 Research
  • Diabetes Management and Research
  • Cancer Research and Treatments
  • Cancer Research and Treatments
  • Transgenic Plants and Applications
  • Asthma and respiratory diseases
  • Transgenic Plants and Applications
  • Peptidase Inhibition and Analysis
  • Immune responses and vaccinations
  • Galectins and Cancer Biology
  • Immunodeficiency and Autoimmune Disorders
  • Food Allergy and Anaphylaxis Research
  • Asthma and respiratory diseases
  • COVID-19 Clinical Research Studies
  • Galectins and Cancer Biology
  • COVID-19 Clinical Research Studies
  • Food Allergy and Anaphylaxis Research
  • Peptidase Inhibition and Analysis
  • Immunodeficiency and Autoimmune Disorders
  • Immune responses and vaccinations
  • Platelet Disorders and Treatments
  • Platelet Disorders and Treatments
  • Vaccine Coverage and Hesitancy
  • Vaccine Coverage and Hesitancy

Keywords (DOAJ)

  • immunology
  • immunotherapy
  • immune system
  • therapeutic vaccines

Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.

Loading community confirmations…
How do we evaluate?Publisher of this journal? Appeal a derived assessment or request a factual correction

The journal's record in other sources:Web of Science MJLDOAJ

Everything shown here is produced automatically from named sources (DOAJ, OpenAlex, Crossref, PubMed, the Norwegian register) as of its capture date, with no human editing. Facts appear as recorded at the source; derived scores (PCI, PTD, PublishLens score) follow a published methodology. Not a judgement on the journal, not an official accreditation, not advice.

Wrong items are corrected automatically by re-reading the source (24 h for daily sources, 7 days for weekly ones) with a dated change log, and each item links to its source record. PublishLens-derived assessments are contested through the appeals mechanism (15 working days). Appeals · Indicator guide

Norwegian register data: Kanalregisteret (HK-dir, Norway) — CC BY 4.0 / NLOD — adapted: level extracted per year · OASPA member list — CC BY

Last automated source read: